Items where authors include "Thomas, D."

Article

Tyrer, F., Gharibzadeh, S., Gillies, C. et al. (1306 more authors) (2025) Incidence of diabetes mellitus following hospitalisation for COVID-19 in the United Kingdom: A prospective observational study. Diabetes, Obesity and Metabolism: A Journal of Pharmacology and Therapeutics, 27 (2). pp. 767-776. ISSN 1462-8902

Gharibzadeh, S., Routen, A., Razieh, C. et al. (1382 more authors) (2025) Long term health outcomes in people with diabetes 12 months after hospitalisation with COVID-19 in the UK: a prospective cohort study. eClinicalMedicine, 79. 103005. ISSN 2589-5370

Colton, H. orcid.org/0000-0002-3287-4103, Barratt, N., Temperton, N. et al. (34 more authors) (2024) Greater preservation of SARS‐CoV‐2 neutralising antibody responses following the ChAdOx1‐S (AZD1222) vaccine compared with mRNA vaccines in haematopoietic cell transplant recipients. British Journal of Haematology, 205 (6). pp. 2206-2218. ISSN 0007-1048

Leavy, O.C., Russell, R.J. orcid.org/0000-0002-0195-0812, Harrison, E.M. et al. (70 more authors) (2024) 1-year health outcomes associated with systemic corticosteroids for COVID-19: a longitudinal cohort study. ERJ Open Research, 10 (5). ISSN 2312-0541

Taquet, M., Skorniewska, Z., De Deyn, T. et al. (1085 more authors) (2024) Cognitive and psychiatric symptom trajectories 2–3 years after hospital admission for COVID-19: a longitudinal, prospective cohort study in the UK. The Lancet Psychiatry, 11 (9). P696-708. ISSN 2215-0366

Goodyear, C.S., Patel, A., Barnes, E. et al. (118 more authors) (2024) Immunogenicity of third dose COVID-19 vaccine strategies in patients who are immunocompromised with suboptimal immunity following two doses (OCTAVE-DUO): an open-label, multicentre, randomised, controlled, phase 3 trial. The Lancet Rheumatology, 6 (6). e339-e351. ISSN 2665-9913

Goodyear, C.S., Patel, A., Barnes, E. et al. (119 more authors) (2024) Immunogenicity of third dose COVID-19 vaccine strategies in patients who are immunocompromised with suboptimal immunity following two doses (OCTAVE-DUO): an open-label, multicentre, randomised, controlled, phase 3 trial. The Lancet Rheumatology, 6 (6). e339-e351. ISSN 2665-9913

Lawson, C.A., Moss, A.J., Arnold, J.R. et al. (1341 more authors) (2024) Long COVID and cardiovascular disease: a prospective cohort study. Open Heart, 11 (1). e002662. ISSN 2053-3624

Liew, F., Efstathiou, C. orcid.org/0000-0001-6125-8126, Fontanella, S. et al. (1457 more authors) (2024) Large-scale phenotyping of patients with long COVID post-hospitalization reveals mechanistic subtypes of disease. Nature Immunology, 25 (4). pp. 607-621. ISSN 1529-2908

Elneima, O., McAuley, H.J.C., Leavy, O.C. et al. (1398 more authors) (2024) Cohort Profile: Post-Hospitalisation COVID-19 (PHOSP-COVID) study. International Journal of Epidemiology, 53 (1). dyad165. ISSN 0300-5771

Elneima, O. orcid.org/0000-0003-2480-8840, McAuley, H.J.C. orcid.org/0000-0001-8997-0764, Leavy, O.C. et al. (1398 more authors) (2024) Cohort profile: post-hospitalisation COVID-19 (PHOSP-COVID) study. International Journal of Epidemiology, 53 (1). dyad165. ISSN 0300-5771

Taquet, M., Skorniewska, Z., Zetterberg, H. orcid.org/0000-0003-3930-4354 et al. (1262 more authors) (2023) Post-acute COVID-19 neuropsychiatric symptoms are not associated with ongoing nervous system injury. Brain Communications, 6 (1). fcad357. ISSN 2632-1297

Taquet, M., Skorniewska, Z., Zetterberg, H. orcid.org/0000-0003-3930-4354 et al. (1262 more authors) (2023) Post-acute COVID-19 neuropsychiatric symptoms are not associated with ongoing nervous system injury. Brain Communications, 6 (1). fcad357. ISSN 2632-1297

Barnes, E. orcid.org/0000-0002-0860-0831, Goodyear, C.S. orcid.org/0000-0001-5926-5941, Willicombe, M. orcid.org/0000-0002-6404-0584 et al. (154 more authors) (2023) SARS-CoV-2-specific immune responses and clinical outcomes after COVID-19 vaccination in patients with immune-suppressive disease. Nature Medicine. ISSN 1078-8956

Barnes, E. orcid.org/0000-0002-0860-0831, Goodyear, C.S. orcid.org/0000-0001-5926-5941, Willicombe, M. orcid.org/0000-0002-6404-0584 et al. (154 more authors) (2023) SARS-CoV-2-specific immune responses and clinical outcomes after COVID-19 vaccination in patients with immune-suppressive disease. Nature Medicine, 29 (7). pp. 1760-1774. ISSN 1078-8956

Loan, J.J.M., Tominey, S., Baweja, K. et al. (160 more authors) (2023) Prospective, multicentre study of screening, investigation and management of hyponatraemia after subarachnoid haemorrhage in the UK and Ireland. Stroke and Vascular Neurology, 8 (3). pp. 207-216. ISSN 2059-8688

Adam, J., Adamczyk, L., Agrawal, N. et al. (436 more authors) (2022) ATHENA detector proposal - a totally hermetic electron nucleus apparatus proposed for IP6 at the Electron-Ion Collider. Journal of Instrumentation. P10019. ISSN 1748-0221

Fenstermacher, M. E., Abbate, J., Abe, S. et al. (827 more authors) (2022) DIII-D research advancing the physics basis for optimizing the tokamak approach to fusion energy. Nuclear Fusion. 042024. ISSN 1741-4326

Fenstermacher, M. E., Abbate, J., Abe, S. et al. (827 more authors) (2022) DIII-D research advancing the physics basis for optimizing the tokamak approach to fusion energy. Nuclear Fusion. 042024. ISSN 1741-4326

Sowerby, J., Thomas, D., Clare, S. et al. (18 more authors) (2017) Nbeal2 is required for neutrophil and NK cell function, and pathogen defence. Journal of Clinical Investigation, 127 (9). pp. 3521-3526. ISSN 0021-9738

Williams, D.J., Archer, R., Archibald, P. et al. (46 more authors) (2016) Comparability: manufacturing, characterization and controls, report of a UK Regenerative Medicine Platform Pluripotent Stem Cell Platform Workshop, Trinity Hall, Cambridge, 14-15 September 2015. Regenerative Medicine, 11 (5). pp. 483-492. ISSN 1746-0751